Screener
Aurinia Pharmaceuticals AUPH Finance Lease Liabilities
Finance Lease Liabilities at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's finance lease liabilities?
- Aurinia Pharmaceuticals (AUPH) reported finance lease liabilities of $43.94M in Q2 2026.
- How has Aurinia Pharmaceuticals's finance lease liabilities changed year-over-year?
- Aurinia Pharmaceuticals's finance lease liabilities decreased by 25.9% year-over-year, from $59.28M to $43.94M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about Aurinia Pharmaceuticals's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude